-
1
-
-
34247204362
-
ABO and platelet transfusion therapy
-
Cooling L. ABO and platelet transfusion therapy. Immunohematology 2007; 23:20-33.
-
(2007)
Immunohematology
, vol.23
, pp. 20-33
-
-
Cooling, L.1
-
2
-
-
34250206997
-
Transfusion of platelets containing ABOincompatible plasma: A survey of 3156 North American laboratories
-
Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABOincompatible plasma: a survey of 3156 North American laboratories. Arch Pathol Lab Med 2007; 131:909-916.
-
(2007)
Arch Pathol Lab Med
, vol.131
, pp. 909-916
-
-
Fung, M.K.1
Downes, K.A.2
Shulman, I.A.3
-
3
-
-
85081453862
-
Process control, selection of compatible blood and blood components for transfusion
-
27th ed. Bethesda, MD: AABB
-
Process control, selection of compatible blood and blood components for transfusion. In: Standards for blood banks and transfusion services. 27th ed. Bethesda, MD: AABB; 2011. p. 35.
-
(2011)
Standards for Blood Banks and Transfusion Services
, pp. 35
-
-
-
5
-
-
0038345479
-
Blood Transfusion: Guidelines for the use of platelet transfusions
-
British Committee for Standards in Haematology
-
British Committee for Standards in Haematology, Blood Transfusion: Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23.
-
(2003)
Br J Haematol
, vol.122
, pp. 10-23
-
-
-
6
-
-
77955126207
-
Practices associated with ABOincompatible platelet transfusions: A BEST Collaborative international survey
-
Lozano M, Heddle N, Williamson LM, et al. Practices associated with ABOincompatible platelet transfusions: a BEST Collaborative international survey. Transfusion 2010; 50:1743-1748.
-
(2010)
Transfusion
, vol.50
, pp. 1743-1748
-
-
Lozano, M.1
Heddle, N.2
Williamson, L.M.3
-
7
-
-
70449092382
-
ABO-identical versus nonidentical platelet transfusion: A systematic review
-
Shehata N, Tinmouth A, Naglie G, et al. ABO-identical versus nonidentical platelet transfusion: a systematic review. Transfusion 2009; 49:2442-2453.
-
(2009)
Transfusion
, vol.49
, pp. 2442-2453
-
-
Shehata, N.1
Tinmouth, A.2
Naglie, G.3
-
8
-
-
84858279134
-
Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: Approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence
-
Henrichs KF, Howk N, Masel DS, et al. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence. Transfusion 2012; 52:635-640.
-
(2012)
Transfusion
, vol.52
, pp. 635-640
-
-
Henrichs, K.F.1
Howk, N.2
Masel, D.S.3
-
9
-
-
77954322331
-
Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: An observational study
-
Pavenski K, Warkentin TE, Shen H, et al. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Transfusion 2010; 50:1552-1560.
-
(2010)
Transfusion
, vol.50
, pp. 1552-1560
-
-
Pavenski, K.1
Warkentin, T.E.2
Shen, H.3
-
10
-
-
84862563756
-
The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypo-proliferative thrombocytopenia
-
Triulzi DJ, Assmann SF, Strauss RG, et al. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypo-proliferative thrombocytopenia. Blood 2012; 23:5553-5562.
-
(2012)
Blood
, vol.23
, pp. 5553-5562
-
-
Triulzi, D.J.1
Assmann, S.F.2
Strauss, R.G.3
-
11
-
-
77149173502
-
Dose of prophylactic platelet transfusions and prevention of hemorrhage
-
Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage.NEngl JMed2010;362:600-613.
-
(2010)
NEngl JMed
, vol.362
, pp. 600-613
-
-
Slichter, S.J.1
Kaufman, R.M.2
Assmann, S.F.3
-
12
-
-
84873420232
-
Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and-B
-
doi: 10.1111/j.1537-2995.2012.03718.x. [Epub ahead of print]
-
Refaai MA, Carter J, Henrichs KF, Davidson DC, Pollock SJ, Casey AE, et al. Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and-B. Transfusion 2012. doi: 10.1111/j.1537-2995.2012.03718. x. [Epub ahead of print]
-
(2012)
Transfusion
-
-
Refaai, M.A.1
Carter, J.2
Henrichs, K.F.3
Davidson, D.C.4
Pollock, S.J.5
Casey, A.E.6
-
13
-
-
83555165281
-
Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients
-
Fontaine MJ, Kuo J, Chen G, et al. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. Transfusion 2011; 51:2611-2618.
-
(2011)
Transfusion
, vol.51
, pp. 2611-2618
-
-
Fontaine, M.J.1
Kuo, J.2
Chen, G.3
-
14
-
-
84865772753
-
Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly 2007-2008: Utility of large administrative databases in blood safety research
-
doi:10.1111/j.1537-2995.2011.03535.x. [Epub ahead of print]
-
Menis M, Izurieta HS, Anderson SA, et al. Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly, 2007-2008: utility of large administrative databases in blood safety research. Transfusion 2012. doi:10.1111/j.1537-2995.2011.03535.x. [Epub ahead of print]
-
(2012)
Transfusion
-
-
Menis, M.1
Izurieta, H.S.2
Anderson, S.A.3
-
15
-
-
69249184319
-
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions
-
Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009; 49:1845-1849.
-
(2009)
Transfusion
, vol.49
, pp. 1845-1849
-
-
Daniel-Johnson, J.1
Leitman, S.2
Klein, H.3
-
16
-
-
81255124181
-
Humoral immunomodulatory effect of influenza vaccine in potential blood donors: Implications for transfusion safety
-
Delaney M, Warner P, Nelson K, et al. Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety. Transfus Med 2011; 21:378-384.
-
(2011)
Transfus Med
, vol.21
, pp. 378-384
-
-
Delaney, M.1
Warner, P.2
Nelson, K.3
-
17
-
-
52949109713
-
Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets
-
Cooling LL, Downs TA, Butch SH, Davenport RD. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion 2008; 48:2106-2113.
-
(2008)
Transfusion
, vol.48
, pp. 2106-2113
-
-
Cooling, L.L.1
Downs, T.A.2
Butch, S.H.3
Davenport, R.D.4
-
18
-
-
75949101859
-
ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies
-
Josephson CD, Castillejo MI, Grima K, Hillyer CD. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010; 42:83-88.
-
(2010)
Transfus Apher Sci
, vol.42
, pp. 83-88
-
-
Josephson, C.D.1
Castillejo, M.I.2
Grima, K.3
Hillyer, C.D.4
-
19
-
-
78651362458
-
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for hightiter ABO antibodies
-
Quillen K, Sheldon SL, Daniel-Johnson JA, et al. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for hightiter ABO antibodies. Transfusion 2011; 51:92-96.
-
(2011)
Transfusion
, vol.51
, pp. 92-96
-
-
Quillen, K.1
Sheldon, S.L.2
Daniel-Johnson, J.A.3
-
20
-
-
84868302276
-
ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions
-
doi: 10.1111/j.1537-2995.2012.03574.x. [Epub ahead of print]
-
Karafin MS, Blagg L, Tobian AA, et al. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012. doi: 10.1111/j.1537-2995.2012.03574.x. [Epub ahead of print]
-
(2012)
Transfusion
-
-
Karafin, M.S.1
Blagg, L.2
Tobian, A.A.3
-
21
-
-
84859731841
-
Current status of additive solutions for platelets
-
Alhumaidan H, Sweeney J. Current status of additive solutions for platelets. J Clin Apher 2012; 27:93-98.
-
(2012)
J Clin Apher
, vol.27
, pp. 93-98
-
-
Alhumaidan, H.1
Sweeney, J.2
-
22
-
-
84859745349
-
A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients
-
Honohan A, Tomson B, van der Bom J, et al. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients. Transfusion 2012; 52:742-751.
-
(2012)
Transfusion
, vol.52
, pp. 742-751
-
-
Honohan, A.1
Tomson, B.2
Van Der Bom, J.3
-
23
-
-
79958731865
-
High concentration plasma-reduced plateletapheresis concentrates
-
Perseghin P. High concentration plasma-reduced plateletapheresis concentrates. Transfus Apher Sci 2011; 44:273-276.
-
(2011)
Transfus Apher Sci
, vol.44
, pp. 273-276
-
-
Perseghin, P.1
-
24
-
-
78349266395
-
In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma
-
Vassallo RR, Adamson JW, Gottschall JL, et al. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50:2376-2385.
-
(2010)
Transfusion
, vol.50
, pp. 2376-2385
-
-
Vassallo, R.R.1
Adamson, J.W.2
Gottschall, J.L.3
-
25
-
-
85081458538
-
In vivo radiolabeled recovery and survival of platelets stored in a new platelet additive solution for 5 days compared to fresh platelets
-
Razatos A, Snyder EL, Wilson K, et al. In vivo radiolabeled recovery and survival of platelets stored in a new platelet additive solution for 5 days compared to fresh platelets. Transfusion 2010;50:64A.
-
(2010)
Transfusion
, vol.50
-
-
Razatos, A.1
Snyder, E.L.2
Wilson, K.3
-
26
-
-
84855356443
-
In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5
-
Radwanski K, Wagner SJ, Skripchenko A, Min K. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Transfusion 2012; 52:188-194.
-
(2012)
Transfusion
, vol.52
, pp. 188-194
-
-
Radwanski, K.1
Wagner, S.J.2
Skripchenko, A.3
Min, K.4
-
27
-
-
84858296374
-
Preparation of single donor platelet with low antibody titers for all patients
-
Romphruk AV, Cheunta S, Pakoate L, et al. Preparation of single donor platelet with low antibody titers for all patients. Transfus Apher Sci 2012; 46:125-128.
-
(2012)
Transfus Apher Sci
, vol.46
, pp. 125-128
-
-
Romphruk, A.V.1
Cheunta, S.2
Pakoate, L.3
|